Hydrochloric Acid → HCID 136508842, compound
Reaction equation
C[O:2][C:3]1[N:8]=[C:7]([N:9]2[CH2:14][CH2:13][O:12][CH2:11][CH2:10]2)[N:6]=[C:5]([NH:15][C@@H:16]2[CH2:21][CH2:20][CH2:19][N:18](C(OC(C)(C)C)=O)[CH2:17]2)[C:4]=1[C:29]1[S:30][C:31]2[C:37]([C:38]([F:41])([F:40])[F:39])=[CH:36][CH:35]=[CH:34][C:32]=2[N:33]=1.Cl>>[N:9]1([C:7]2[NH:8][C:3](=[O:2])[C:4]([C:29]3[S:30][C:31]4[C:37]([C:38]([F:40])([F:39])[F:41])=[CH:36][CH:35]=[CH:34][C:32]=4[N:33]=3)=[C:5]([NH:15][C@@H:16]3[CH2:21][CH2:20][CH2:19][NH:18][CH2:17]3)[N:6]=2)[CH2:14][CH2:13][O:12][CH2:11][CH2:10]1Participants
Procedure
Following the same procedure as in step 4 of Example 337 using tert-butyl (3R)-3-[[6-methoxy-2-(morpholin-4-yl)-5-[7-(trifluoromethyl)-1,3-benzothiazol-2-yl]pyrimidin-4-yl]amino]piperidine-1-carboxylate (40.0 mg, 0.07 mmol, 1.00 equiv) and conce. hydrochloric acid (3.0 mL). The crude product was triturated in methanol and dissolved in 5.0 ml of water. The pH value of the solution was adjusted to 11 with sodium hydroxide (1 M). The solid was collected by filtration and dried in vacuo to afford the title compound. Yield: 16.1 mg (50%). 1H-NMR (400 MHz, DMSO-d6): ppm 1.54-1.57(m, 1H), 1.63-1.73(m, 2H), 1.94(m, 1H), 2.64-2.82(m, 3H), 3.08-3.11(m, 1H), 3.69-3.70(m, 8H), 4.17-4.18(m, 1H), 7.57-7.63(m, 2H), 8.00-8.02(d, J=7.6 Hz, 1H), 10.69-10.71(m, 1H); 19F-NMR (300 MHz, DMSO-d6): ppm −61.57; MS m/z [M+H]+ (ESI): 481. IRAK4 IC50=520 nM
Workup
- customThe crude product was triturated in methanol
- dissolutiondissolved in 5.0 ml of water
- filtrationThe solid was collected by filtration
- customdried in vacuo
Sources & evidence
- ORD record
- ord-6d6fec9a2c5c4e788047a05d9659c43a
- Source dataset
- uspto-grants-2015_12
- Patent number
- US09221809B2
Reaction notes
Loading…